Financials data is unavailable for this security.
View more
Year on year Chunghwa Chemical Synthesis & Biotech Co Ltd 's net income fell -43.14% from 465.87m to 264.91m despite flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 54.57% to 63.70%.
| Gross margin | 32.33% |
|---|---|
| Net profit margin | 7.81% |
| Operating margin | 5.48% |
| Return on assets | 2.37% |
|---|---|
| Return on equity | 3.53% |
| Return on investment | 2.73% |
More ▼
Cash flow in TWDView more
In 2023, cash reserves at Chunghwa Chemical Synthesis & Biotech Co Ltd fell by 31.05m. Cash Flow from Financing totalled 496.57m or 23.80% of revenues. In addition the company used 66.27m for operations while cash used for investing totalled 461.32m.
| Cash flow per share | 3.98 |
|---|---|
| Price/Cash flow per share | 10.58 |
| Book value per share | 43.16 |
|---|---|
| Tangible book value per share | 43.10 |
More ▼
Balance sheet in TWDView more
| Current ratio | 2.46 |
|---|---|
| Quick ratio | 0.7205 |
| Total debt/total equity | 0.3013 |
|---|---|
| Total debt/total capital | 0.2315 |
More ▼
Growth rates in TWD
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -38.46% and -42.84%, respectively. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 2.01% |
|---|---|
| Div growth rate (5 year) | -7.79% |
| Payout ratio (TTM) | 52.72% |
| EPS growth(5 years) | 2.55 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -70.44 |
More ▼
